NexImmune (OTCMKTS:NEXI) vs. Bio-Path (NASDAQ:BPTH) Head to Head Contrast

NexImmune (OTCMKTS:NEXI) vs. Bio-Path (NASDAQ:BPTH) Head to Head Contrast

Volatility and Risk Bio-Path has a beta of -0.14, meaning that its stock price is 114% less volatile than the S&P 500. Comparatively, NexImmune has a beta of -2289.14, meaning that its stock price is 229,014% less volatile than the S&P 500. Insider and Institutional Ownership 5.7% of Bio-Path shares are held by institutional investors. Comparatively, 9.9% of NexImmune shares are held by institutional investors. 0.7% of Bio-Path shares are held b…